Mechanism Of Action

Edit

An Oral Pan-viral Protease Inhibitor for the Prevention and Treatment of Norovirus and Coronavirus Infections: Mechanism of Action and Phase 1 Study Results (Cocrystal Pharma Inc)

Public Technologies 05 Aug 2025

An Oral Pan-viral Protease Inhibitor for the Prevention and Treatment of Norovirus and Coronavirus Infections. Mechanism of Action and Phase 1 Study Results ... Drug candidates with clinically validated mechanisms of action.

Edit

NKGen Biotech Presents Troculeucel Mechanism of Action with Corresponding Phase 1 Biomarker Data at the ...

Nasdaq Globe Newswire 28 Jul 2025

NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of ...

Edit

NFL Biosciences Announces a Scientific Collaboration with McLean Hospital (Boston, USA) to Further Investigate the Mechanism of Action of NFL-101 (NFL Biosciences SA)

Public Technologies 28 Jul 2025

"With botanical drugs, efficacy often relies on the full extract, making it challenging to identify a precise mechanism of action ... The next stage is to better understand the mechanism of action, ...

Edit

Nanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology

The Facts 22 Jul 2025

New research paper highlights the unique structure and function of Nanoscope's synthetic opsin, supporting its potential in vision restoration ....

Edit

Hidradenitis Suppurativa Pipeline Analysis 2025: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of ...

GetNews 22 Jul 2025

Hidradenitis Suppurativa Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

Edit

July 16, 2025Suven Life Sciences announces First Patient Randomized in Phase-2b Clinical Trial of Ropanicant, an a4ß2 Antagonist representing a Novel Mechanism of Action for the treatment of Major Depressive Disorder (Suven Life Sciences Limited)

Public Technologies 17 Jul 2025

News Release Suven Life Sciences announces First Patient Randomized in Phase-2b Clinical Trial of Ropanicant, an α4β2 Antagonist representing a Novel Mechanism of Action for the treatment of Major Depressive Disorder.

Edit

Myositis Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism of Action, ...

GetNews 16 Jul 2025

Myositis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

Edit

Nontuberculous Mycobacterial Infections Pipeline 2025: Mechanism of Action, Route of Administration, and Clinical Trial Insights ...

GetNews 08 Jul 2025

Nontuberculous Mycobacterial Infections Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

Edit

Follicular Lymphoma Pipeline 2025: Mechanism of Action, Route of Administration, and Clinical Trial Insights Explored ...

GetNews 25 Jun 2025

Follicular Lymphoma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

Edit

Publication in Alzheimer’s & Dementia Elucidates Multimodal Mechanism of Action Underpinning Promising New Neuromodulation Therapy ...

Business Wire 18 Jun 2025

The Journal of the Alzheimer’s Association delivers a landmark synthesis of evidence that positions ...

Edit